Prospective multicEntric NonranDomized Registry

NCT02496169 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2015-07-14

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and efficacy of the eucaLimus Sirolimus Eluting stent system in patients with de novo coronary lesions.

Conditions

Interventions

DEVICE

eucaLimus

Percutaneous Coronary Intervention (PCI)

Sponsors & Collaborators

  • CERES GmbH

    collaborator INDUSTRY
  • Eucatech AG

    lead INDUSTRY

Principal Investigators

  • Jean-Marc Pernes, Dr. · Hôpital privé d' Antony 1 rue Velpeau 92160 Antony, France

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2016-12-31
Completion
2017-12-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02496169 on ClinicalTrials.gov